AZN (AstraZeneca) Tax Rate % : 9.96% (As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. AstraZeneca's Tax Expense for the three months ended in Dec. 2024 was $166 Mil. AstraZeneca's Pre-Tax Income for the three months ended in Dec. 2024 was $1,666 Mil. Therefore, AstraZeneca's Tax Rate % for the quarter that ended in Dec. 2024 was 9.96%.

AstraZeneca Tax Rate % Historical Data

The historical data trend for AstraZeneca's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Tax Rate % Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Tax Rate %

Get a 7-Day Free Trial

19.71

143.40

-31.67

13.60

18.99

AstraZeneca Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Tax Rate %	Get a 7-Day Free Trial															-6.91	22.14	19.57	21.61	9.96

AstraZeneca Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

AstraZeneca's Tax Rate % for the fiscal year that ended in Dec. 2024 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2024 )	/	Pre-Tax Income (A: Dec. 2024 )
	=	1650	/	8691
	=	18.99 %

AstraZeneca's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2024 )	/	Pre-Tax Income (Q: Dec. 2024 )
	=	166	/	1666
	=	9.96 %

AstraZeneca Tax Rate % Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:Sweden AZN1:Mexico AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.